Edison Oncology Unveils Data On EO1001 And EO?4426
24 Nov 2025 //
ACCESSWIRE
Edison Oncology Present 2 Posters At AACR-NCI-EORTC Conference
27 Oct 2025 //
ACCESSWIRE
Edison Reports Promising Interim Data from Ongoing Orotecan® Clinical Trial
08 Apr 2024 //
PR NEWSWIRE
Edison Oncology Announces Presentation of Two Scientific Posters at AACR Meeting
20 Apr 2023 //
PR NEWSWIRE
Edison Oncology Partners DNA-damage Response Inhibitor Program with Rakovina
31 Mar 2021 //
PRNEWSWIRE

Market Place
Sourcing Support